Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLX51107 for Steroid-Refractory Acute GVHD
NCT04910152Phase 2Terminated
- Start
- Apr 2022
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of PLX51107 in Acute Graft-Versus-Host Disease (aGvHD). Started Apr 2022; status: terminated.
02
Drugs
PLX51107
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT04910152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04910152.